BACKGROUND: The trauma transfusion literature has yet to resolve which is more important for hemorrhaging patients, transfusing plasma and platelets along with red blood cells (RBCs) early in resuscitation or gradually balancing blood product ratios. In a previous report of PROMMTT results, we found (1) plasma and platelet:RBC ratios increased gradually during the 6 hours following admission, and (2) patients achieving ratios more than 1:2 (relative to ratios <1:2) had significantly decreased 6-hour to 24-hour mortality adjusting for baseline and time-varying covariates. To differentiate the association of in-hospital mortality with early plasma or platelet transfusion from that with delayed but gradually balanced ratios, we developed a separate analytic approach. METHODS: Using PROMMTT data and multilevel logistic regression to adjust for center effects, we related in-hospital mortality to the early receipt of plasma or platelets within the first three to six transfusion units (including RBCs) and 2.5 hours of admission. We adjusted for the same covariates as in our previous report: Injury Severity Score (ISS), age, time and total number of blood product transfusions upon entry to the analysis cohort, and bleeding from the head, chest, or limb. RESULTS: Of 1,245 PROMMTT patients, 619 were eligible for this analysis. Early plasma was associated with decreased 24-hour and 30-day mortality (adjusted odds ratios of 0.47 [p = 0.009] and 0.44 [p = 0.002], respectively). Too few patients (24) received platelets early for meaningful assessment. In the subgroup of 222 patients receiving no early plasma but continuing transfusions beyond Hour 2.5, achieving gradually balanced plasma and platelet:RBC ratios of 1:2 or greater by Hour 4 was not associated with 30-day mortality (adjusted odds ratios of 0.9 and 1.1, respectively). There were no significant center effects. CONCLUSION: Plasma transfusion early in resuscitation had a protective association with mortality, whereas delayed but gradually balanced transfusion ratios did not. Further research will require considerably larger numbers of patients receiving platelets early.
BACKGROUND: The trauma transfusion literature has yet to resolve which is more important for hemorrhagingpatients, transfusing plasma and platelets along with red blood cells (RBCs) early in resuscitation or gradually balancing blood product ratios. In a previous report of PROMMTT results, we found (1) plasma and platelet:RBC ratios increased gradually during the 6 hours following admission, and (2) patients achieving ratios more than 1:2 (relative to ratios <1:2) had significantly decreased 6-hour to 24-hour mortality adjusting for baseline and time-varying covariates. To differentiate the association of in-hospital mortality with early plasma or platelet transfusion from that with delayed but gradually balanced ratios, we developed a separate analytic approach. METHODS: Using PROMMTT data and multilevel logistic regression to adjust for center effects, we related in-hospital mortality to the early receipt of plasma or platelets within the first three to six transfusion units (including RBCs) and 2.5 hours of admission. We adjusted for the same covariates as in our previous report: Injury Severity Score (ISS), age, time and total number of blood product transfusions upon entry to the analysis cohort, and bleeding from the head, chest, or limb. RESULTS: Of 1,245 PROMMTT patients, 619 were eligible for this analysis. Early plasma was associated with decreased 24-hour and 30-day mortality (adjusted odds ratios of 0.47 [p = 0.009] and 0.44 [p = 0.002], respectively). Too few patients (24) received platelets early for meaningful assessment. In the subgroup of 222 patients receiving no early plasma but continuing transfusions beyond Hour 2.5, achieving gradually balanced plasma and platelet:RBC ratios of 1:2 or greater by Hour 4 was not associated with 30-day mortality (adjusted odds ratios of 0.9 and 1.1, respectively). There were no significant center effects. CONCLUSION: Plasma transfusion early in resuscitation had a protective association with mortality, whereas delayed but gradually balanced transfusion ratios did not. Further research will require considerably larger numbers of patients receiving platelets early.
Authors: Matthew D Neal; Alyce Marsh; Ryan Marino; Benjamin Kautza; Jay S Raval; Raquel M Forsythe; Gary T Marshall; Jason L Sperry Journal: Arch Surg Date: 2012-06
Authors: Jon Michael Gran; Kjetil Røysland; Marcel Wolbers; Vanessa Didelez; Jonathan A C Sterne; Bruno Ledergerber; Hansjakob Furrer; Viktor von Wyl; Odd O Aalen Journal: Stat Med Date: 2010-11-20 Impact factor: 2.373
Authors: John D Roback; Stephen Caldwell; Jeff Carson; Robertson Davenport; Mary Jo Drew; Anne Eder; Mark Fung; Marilyn Hamilton; John R Hess; Naomi Luban; Jeremy G Perkins; Bruce S Sachais; Aryeh Shander; Toby Silverman; Ed Snyder; Christopher Tormey; John Waters; Ben Djulbegovic Journal: Transfusion Date: 2010-03-19 Impact factor: 3.157
Authors: Andrew P Cap; Philip C Spinella; Matthew A Borgman; Lorne H Blackbourne; Jeremy G Perkins Journal: J Trauma Acute Care Surg Date: 2012-08 Impact factor: 3.313
Authors: Scott C Brakenridge; Herb A Phelan; Steven S Henley; Richard M Golden; T Michael Kashner; Alexander E Eastman; Jason L Sperry; Brian G Harbrecht; Ernest E Moore; Joseph Cuschieri; Ronald V Maier; Joseph P Minei Journal: J Trauma Date: 2011-08
Authors: Andreas R de Biasi; Lynn G Stansbury; Richard P Dutton; Deborah M Stein; Thomas M Scalea; John R Hess Journal: Transfusion Date: 2011-02-18 Impact factor: 3.157
Authors: Christopher W Snyder; Jordan A Weinberg; Gerald McGwin; Sherry M Melton; Richard L George; Donald A Reiff; James M Cross; Jennifer Hubbard-Brown; Loring W Rue; Jeffrey D Kerby Journal: J Trauma Date: 2009-02
Authors: Demetrios Demetriades; James Murray; Kiriakos Charalambides; Kathy Alo; George Velmahos; Peter Rhee; Linda Chan Journal: J Am Coll Surg Date: 2004-01 Impact factor: 6.113
Authors: John B Holcomb; Barbara C Tilley; Sarah Baraniuk; Erin E Fox; Charles E Wade; Jeanette M Podbielski; Deborah J del Junco; Karen J Brasel; Eileen M Bulger; Rachael A Callcut; Mitchell Jay Cohen; Bryan A Cotton; Timothy C Fabian; Kenji Inaba; Jeffrey D Kerby; Peter Muskat; Terence O'Keeffe; Sandro Rizoli; Bryce R H Robinson; Thomas M Scalea; Martin A Schreiber; Deborah M Stein; Jordan A Weinberg; Jeannie L Callum; John R Hess; Nena Matijevic; Christopher N Miller; Jean-Francois Pittet; David B Hoyt; Gail D Pearson; Brian Leroux; Gerald van Belle Journal: JAMA Date: 2015-02-03 Impact factor: 56.272
Authors: Benjamin R Huebner; Ernest E Moore; Hunter B Moore; Angela Sauaia; Gregory Stettler; Monika Dzieciatkowska; Kirk Hansen; Anirban Banerjee; Christopher C Silliman Journal: Transfusion Date: 2017-05-12 Impact factor: 3.157
Authors: Rachael A Callcut; Michael W Cripps; Mary F Nelson; Amanda S Conroy; Bryce B R Robinson; Mitchell J Cohen Journal: J Trauma Acute Care Surg Date: 2016-03 Impact factor: 3.313
Authors: Matthew C Hernandez; Cornelius A Thiels; Johnathon M Aho; Elizabeth B Habermann; Martin D Zielinski; James A Stubbs; Donald H Jenkins; Scott P Zietlow Journal: J Trauma Acute Care Surg Date: 2017-09 Impact factor: 3.313
Authors: Charlotte Mae K Waits; Aaron Bower; Kelli N Simms; Bradford C Feldman; Nathan Kim; Susan Sergeant; Floyd H Chilton; Pamela J VandeVord; Carl D Langefeld; Elaheh Rahbar Journal: J Neurotrauma Date: 2020-05-07 Impact factor: 5.269
Authors: Sangbum Choi; Mohammad H Rahbar; Jing Ning; Deborah J Del Junco; Elaheh Rahbar; Chuan Hong; Jin Piao; Erin E Fox; John B Holcomb Journal: J Clin Epidemiol Date: 2016-04-29 Impact factor: 6.437
Authors: Elaheh Rahbar; Erin E Fox; Deborah J del Junco; John A Harvin; John B Holcomb; Charles E Wade; Martin A Schreiber; Mohammad H Rahbar; Eileen M Bulger; Herb A Phelan; Karen J Brasel; Louis H Alarcon; John G Myers; Mitchell J Cohen; Peter Muskat; Bryan A Cotton Journal: J Trauma Acute Care Surg Date: 2013-07 Impact factor: 3.313